PubMed

Characterization of pig slurry with reference to flocculation and separation.

Christensen ML, Hjorth M, Keiding K.

Water Res. 2009 Feb;43(3):773-83. Epub 2008 Nov 21.PMID: 19081594 [PubMed - indexed for MEDLINE]Related articles

GAD treatment and insulin secretion in recent-onset type 1 diabetes.

Ludvigsson J, Faresjö M, Hjorth M, Axelsson S, Chéramy M, Pihl M, Vaarala O, Forsander G, Ivarsson S, Johansson C, Lindh A, Nilsson NO, Aman J, Ortqvist E, Zerhouni P, Casas R.

N Engl J Med. 2008 Oct 30;359(18):1909-20. Epub 2008 Oct 8.PMID: 18843118 [PubMed - indexed for MEDLINE]Related articlesFree article

Interactions between phosphorus feeding strategies for pigs and dairy cows and separation efficiency of slurry.

Sommer SG, Maahn M, Poulsen HD, Hjorth M, Sehested J.

Environ Technol. 2008 Jan;29(1):75-80.PMID: 18610547 [PubMed - indexed for MEDLINE]Related articles

Flocculation, coagulation, and precipitation of manure affecting three separation techniques.

Hjorth M, Christensen ML, Christensen PV.

Bioresour Technol. 2008 Dec;99(18):8598-604. Epub 2008 May 12.PMID: 18474422 [PubMed - indexed for MEDLINE]Related articles

Cyclophosphamide plus dexamethasone is an efficient initial treatment before high-dose melphalan and autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of a randomized comparison with vincristine, doxorubicin, and dexamethasone.

Mellqvist UH, Lenhoff S, Johnsen HE, Hjorth M, Holmberg E, Juliusson G, Tangen JM, Westin J; Nordic Myeloma Study Group.

Cancer. 2008 Jan 1;112(1):129-35.PMID: 17973267 [PubMed - indexed for MEDLINE]Related articlesFree article

A community outbreak of Legionnaires' disease from an industrial cooling tower: assessment of clinical features and diagnostic procedures.

Hugosson A, Hjorth M, Bernander S, Claesson BE, Johansson A, Larsson H, Nolskog P, Pap J, Svensson N, Ulleryd P.

Scand J Infect Dis. 2007;39(3):217-24.PMID: 17366051 [PubMed - indexed for MEDLINE]Related articles

Serum calcium is an independent predictor of quality of life in multiple myeloma.

Wisløff F, Kvam AK, Hjorth M, Lenhoff S.

Eur J Haematol. 2007 Jan;78(1):29-34. Epub 2006 Oct 13.PMID: 17038019 [PubMed - indexed for MEDLINE]Related articles

Intensive therapy for multiple myeloma in patients younger than 60 years. Long-term results focusing on the effect of the degree of response on survival and relapse pattern after transplantation.

Lenhoff S, Hjorth M, Turesson I, Westin J, Gimsing P, Wislöff F, Ahlberg L, Carlson K, Christiansen I, Dahl IM, Forsberg K, Brinch L, Hammerström J, Johnsen HE, Knudsen LM, Linder O, Mellqvist UH, Nesthus I, Nielsen JL; Nordic Myeloma Study Group.

Haematologica. 2006 Sep;91(9):1228-33.PMID: 16956822 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of age on survival after intensive therapy for multiple myeloma: a population-based study by the Nordic Myeloma Study Group.

Lenhoff S, Hjorth M, Westin J, Brinch L, Bäckström B, Carlson K, Christiansen I, Dahl IM, Gimsing P, Hammerström J, Johnsen HE, Juliusson G, Linder O, Mellqvist UH, Nesthus I, Nielsen JL, Tangen JM, Turesson I; Nordic Myeloma Study Group.

Br J Haematol. 2006 May;133(4):389-96.PMID: 16643445 [PubMed - indexed for MEDLINE]Related articles

Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months.

Schulman S, Lindmarker P, Holmström M, Lärfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M.

J Thromb Haemost. 2006 Apr;4(4):734-42.PMID: 16634738 [PubMed - indexed for MEDLINE]Related articles

An easy and rapid method using microscopy to determine herbicide effects in Poaceae weed species.

Hjorth M, Mondolot L, Buatois B, Andary C, Rapior S, Kudsk P, Mathiassen SK, Ravn HW.

Pest Manag Sci. 2006 Jun;62(6):515-21.PMID: 16628541 [PubMed - indexed for MEDLINE]Related articles

Systematic re-examination of carriers of balanced reciprocal translocations: a strategy to search for candidate regions for common and complex diseases.

Bache I, Hjorth M, Bugge M, Holstebroe S, Hilden J, Schmidt L, Brondum-Nielsen K, Bruun-Petersen G, Jensen PK, Lundsteen C, Niebuhr E, Rasmussen K, Tommerup N.

Eur J Hum Genet. 2006 Apr;14(4):410-7.PMID: 16493440 [PubMed - indexed for MEDLINE]Related articlesFree article

The use of (14)C tracer technique to assess the functional response of zooplankton community grazing to toxic impact.

Hjorth M, Haller R, Dahllöf I.

Mar Environ Res. 2006 Apr;61(3):339-51. Epub 2005 Dec 28.PMID: 16386297 [PubMed - indexed for MEDLINE]Related articles

Effects on the function of three trophic levels in marine plankton communities under stress from the antifouling compound zinc pyrithione.

Hjorth M, Dahllöf I, Forbes VE.

Aquat Toxicol. 2006 Apr 20;77(1):105-15. Epub 2005 Dec 13.PMID: 16352351 [PubMed - indexed for MEDLINE]Related articles

New phytochemical screening method for biomarkers in plants exposed to herbicides.

Ravn HW, Hjorth M, Lauridsen L, Kudsk P, Mathiassen SK, Mondolot L.

Bull Environ Contam Toxicol. 2005 Aug;75(2):236-45. No abstract available. PMID: 16222492 [PubMed - indexed for MEDLINE]Related articles

Quality of life may be affected more by disease parameters and response to therapy than by haemoglobin changes.

Wisløff F, Gulbrandsen N, Hjorth M, Lenhoff S, Fayers P.

Eur J Haematol. 2005 Oct;75(4):293-8.PMID: 16146535 [PubMed - indexed for MEDLINE]Related articles

Toxicity in standard melphalan-prednisone therapy among myeloma patients with renal failure--a retrospective analysis and recommendations for dose adjustment.

Carlson K, Hjorth M, Knudsen LM; Nordic Myeloma Study Group.

Br J Haematol. 2005 Mar;128(5):631-5.PMID: 15725084 [PubMed - indexed for MEDLINE]Related articles

An excess of chromosome 1 breakpoints in male infertility.

Bache I, Assche EV, Cingoz S, Bugge M, Tümer Z, Hjorth M, Lundsteen C, Lespinasse J, Winther K, Niebuhr A, Kalscheuer V, Liebaers I, Bonduelle M, Tournaye H, Ayuso C, Barbi G, Blennow E, Bourrouillou G, Brondum-Nielsen K, Bruun-Petersen G, Croquette MF, Dahoun S, Dallapiccola B, Davison V, Delobel B, Duba HC, Duprez L, Ferguson-Smith M, Fitzpatrick DR, Grace E, Hansmann I, Hultén M, Jensen PK, Jonveaux P, Kristoffersson U, Lopez-Pajares I, McGowan-Jordan J, Murken J, Orera M, Parkin T, Passarge E, Ramos C, Rasmussen K, Schempp W, Schubert R, Schwinger E, Shabtai F, Smith K, Stallings R, Stefanova M, Tranebjerg L, Turleau C, van der Hagen CB, Vekemans M, Vokac NK, Wagner K, Wahlstroem J, Zelante L, Tommerup N.

Eur J Hum Genet. 2004 Dec;12(12):993-1000.PMID: 15367911 [PubMed - indexed for MEDLINE]Related articlesFree article

Early response predicts thalidomide efficiency in patients with advanced multiple myeloma.

Waage A, Gimsing P, Juliusson G, Turesson I, Gulbrandsen N, Eriksson T, Hjorth M, Nielsen JL, Lenhoff S, Westin J, Wislöff F; Nordic Myeloma Study Group.

Br J Haematol. 2004 Apr;125(2):149-55.PMID: 15059136 [PubMed - indexed for MEDLINE]Related articles

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life.

Hellström-Lindberg E, Gulbrandsen N, Lindberg G, Ahlgren T, Dahl IM, Dybedal I, Grimfors G, Hesse-Sundin E, Hjorth M, Kanter-Lewensohn L, Linder O, Luthman M, Löfvenberg E, Oberg G, Porwit-MacDonald A, Rådlund A, Samuelsson J, Tangen JM, Winquist I, Wisloff F; Scandinavian MDS Group.

Br J Haematol. 2003 Mar;120(6):1037-46.PMID: 12648074 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support.

Gulbrandsen N, Wisløff F, Brinch L, Carlson K, Dahl IM, Gimsing P, Hippe E, Hjorth M, Knudsen LM, Lamvik J, Lenhoff S, Løfvenberg E, Nesthus I, Nielsen JL, Turesson I, Westin J; Nordic Myeloma Study Group.

Med Oncol. 2001;18(1):65-77.PMID: 11778972 [PubMed - indexed for MEDLINE]Related articles

Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease.

Seidel C, Hjertner Ø, Abildgaard N, Heickendorff L, Hjorth M, Westin J, Nielsen JL, Hjorth-Hansen H, Waage A, Sundan A, Børset M; Nordic Myeloma Study Group.

Blood. 2001 Oct 1;98(7):2269-71.PMID: 11568016 [PubMed - indexed for MEDLINE]Related articlesFree article

Cost-utility analysis of high-dose melphalan with autologous blood stem cell support vs. melphalan plus prednisone in patients younger than 60 years with multiple myeloma.

Gulbrandsen N, Wisløff F, Nord E, Lenhoff S, Hjorth M, Westin J; Nordic Myeloma Study Group.

Eur J Haematol. 2001 May;66(5):328-36.PMID: 11422413 [PubMed - indexed for MEDLINE]Related articles

[High-dose melphalan with stem cell support is now an established myeloma therapy. Treatment of myeloma from a 30-year perspective]

Hjorth M, Lenhoff S, Turesson I, Westin J.

Lakartidningen. 2000 Oct 11;97(41):4585-6, 4589-92. Swedish. PMID: 11107744 [PubMed - indexed for MEDLINE]Related articles

Renal failure in multiple myeloma: reversibility and impact on the prognosis. Nordic Myeloma Study Group.

Knudsen LM, Hjorth M, Hippe E.

Eur J Haematol. 2000 Sep;65(3):175-81.PMID: 11007053 [PubMed - indexed for MEDLINE]Related articles

Serum syndecan-1: a new independent prognostic marker in multiple myeloma.

Seidel C, Sundan A, Hjorth M, Turesson I, Dahl IM, Abildgaard N, Waage A, Borset M.

Blood. 2000 Jan 15;95(2):388-92. Erratum in: Blood 2000 Apr 1;95(7):2197. PMID: 10627439 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact on survival of high-dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic Myeloma Study Group.

Lenhoff S, Hjorth M, Holmberg E, Turesson I, Westin J, Nielsen JL, Wislöff F, Brinch L, Carlson K, Carlsson M, Dahl IM, Gimsing P, Hippe E, Johnsen H, Lamvik J, Löfvenberg E, Nesthus I, Rödjer S.

Blood. 2000 Jan 1;95(1):7-11.PMID: 10607678 [PubMed - indexed for MEDLINE]Related articlesFree article

Prognostic evaluation in multiple myeloma: an analysis of the impact of new prognostic factors.

Turesson I, Abildgaard N, Ahlgren T, Dahl I, Holmberg E, Hjorth M, Nielsen JL, Odén A, Seidel C, Waage A, Westin J, Wislöff F.

Br J Haematol. 1999 Sep;106(4):1005-12.PMID: 10520004 [PubMed - indexed for MEDLINE]Related articles

Survival in conventionally treated younger (<60 years) multiple myeloma patients: no improvement during two decades. Nordic Myeloma Study Group (NMSG).

Hjorth M, Holmberg E, Rödjer S, Turesson I, Westin J, Wislöff F.

Eur J Haematol. 1999 Apr;62(4):271-7.PMID: 10227461 [PubMed - indexed for MEDLINE]Related articles

Development of an EORTC questionnaire module to be used in health-related quality-of-life assessment for patients with multiple myeloma. European Organization for Research and Treatment of Cancer Study Group on Quality of Life.

Stead ML, Brown JM, Velikova G, Kaasa S, Wisløff F, Child JA, Hippe E, Hjorth M, Sezer O, Selby P.

Br J Haematol. 1999 Mar;104(3):605-11.PMID: 10086801 [PubMed - indexed for MEDLINE]Related articles

Cost-utility analysis of melphalan plus prednisone with or without interferon-alpha 2b in newly diagnosed multiple myeloma. Results from a randomised controlled trial.

Nord E, Wisløff F, Hjorth M, Westin J.

Pharmacoeconomics. 1997 Jul;12(1):89-103.PMID: 10169390 [PubMed - indexed for MEDLINE]Related articles

Health-related quality of life assessed before and during chemotherapy predicts for survival in multiple myeloma. Nordic Myeloma Study Group.

Wisløff F, Hjorth M.

Br J Haematol. 1997 Apr;97(1):29-37.PMID: 9136939 [PubMed - indexed for MEDLINE]Related articles

Physicians' attitudes toward clinical trials and their relationship to patient accrual in a Nordic multicenter study on myeloma.

Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J.

Control Clin Trials. 1996 Oct;17(5):372-86.PMID: 8932971 [PubMed - indexed for MEDLINE]Related articles

Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group.

Wisløff F, Hjorth M, Kaasa S, Westin J.

Br J Haematol. 1996 Aug;94(2):324-32.PMID: 8759893 [PubMed - indexed for MEDLINE]Related articles

Measurement of health-related quality of life in multiple myeloma. Nordic Myeloma Study Group.

Wisløff F, Eika S, Hippe E, Hjorth M, Holmberg E, Kaasa S, Palva I, Westin J.

Br J Haematol. 1996 Mar;92(3):604-13.PMID: 8616024 [PubMed - indexed for MEDLINE]Related articles

Patient accrual and quality of participation in a multicentre study on myeloma: a comparison between major and minor participating centres.

Hjorth M, Holmberg E, Rödjer S, Taube A, Westin J.

Br J Haematol. 1995 Sep;91(1):109-15.PMID: 7577616 [PubMed - indexed for MEDLINE]Related articles

Interferon alfa-2b versus no maintenance therapy during the plateau phase in multiple myeloma: a randomized study. Cooperative Study Group.

Westin J, Rödjer S, Turesson I, Cortelezzi A, Hjorth M, Zador G.

Br J Haematol. 1995 Mar;89(3):561-8.PMID: 7734355 [PubMed - indexed for MEDLINE]Related articles

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

Knudsen LM, Hippe E, Hjorth M, Holmberg E, Westin J.

Eur J Haematol. 1994 Oct;53(4):207-12.PMID: 7957804 [PubMed - indexed for MEDLINE]Related articles

Initial versus deferred melphalan-prednisone therapy for asymptomatic multiple myeloma stage I--a randomized study. Myeloma Group of Western Sweden.

Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J.

Eur J Haematol. 1993 Feb;50(2):95-102.PMID: 8440364 [PubMed - indexed for MEDLINE]Related articles

Impact of active and passive exclusions on the results of a clinical trial in multiple myeloma. The Myeloma Group of Western Sweden.

Hjorth M, Holmberg E, Rödjer S, Westin J.

Br J Haematol. 1992 Jan;80(1):55-61.PMID: 1536810 [PubMed - indexed for MEDLINE]Related articles

Interferon therapy during the plateau phase of multiple myeloma: an update of the Swedish study.

Westin J, Cortelezzi A, Hjorth M, Rödjer S, Turesson I, Zador G.

Eur J Cancer. 1991;27 Suppl 4:S45-8.PMID: 1799477 [PubMed - indexed for MEDLINE]Related articles

Initial treatment in multiple myeloma: no advantage of multidrug chemotherapy over melphalan-prednisone. The Myeloma Group of Western Sweden.

Hjorth M, Hellquist L, Holmberg E, Magnusson B, Rödjer S, Westin J.

Br J Haematol. 1990 Feb;74(2):185-91.PMID: 2180471 [PubMed - indexed for MEDLINE]Related articles

Chlorpromazine, methotrimeprazine, and metabolites. Structural changes accompanying the loss of neuroleptic potency by ring sulfoxidation.

Dahl SG, Hjorth M, Hough E.

Mol Pharmacol. 1982 Mar;21(2):409-14.PMID: 6124878 [PubMed - indexed for MEDLINE]Related articles

Serum tryptophan levels in alcoholics.

Hjorth M, Bille M, Smith DF.

Drug Alcohol Depend. 1981 Apr;7(2):157-61.PMID: 7249925 [PubMed - indexed for MEDLINE]Related articles

Empiric treatment of fever in acute leukaemia with tobramycin-cephalothin, and the escape clause provision of corticosteroids.

Hjorth M, Weinfeld A, Brorson JE.

Scand J Infect Dis. 1980;12(2):139-48.PMID: 7375825 [PubMed - indexed for MEDLINE]Related articles

A hypotriploid stemline with 4 Ph1 chromosomes in erythroleukemic blast crisis of a CML-patient with a long survival time.

Hjorth M, Mark J, Tibblin E.

Hereditas. 1980;93(2):333-6. No abstract available. PMID: 6934171 [PubMed - indexed for MEDLINE]Related articles